ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
AVENUE THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.43+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $1.42M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Avenue Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 8, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 30, 2025 | Dec 31, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 30, 2025 | Dec 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Nov 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 24, 2025 | Apr 30, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2025 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 7, 2025 | Mar 7, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 26, 2024 | Nov 29, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 23, 2024 | Sep 27, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 9, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 9, 2024 | Aug 9, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2024 | Jun 26, 2024 | SEC EDGAR |
| Current report | 8-K | May 21, 2024 | May 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 15, 2024 | SEC EDGAR |
| Current report | 8-K | May 15, 2024 | May 15, 2024 | SEC EDGAR |
| Current report | 8-K | May 10, 2024 | May 13, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 22, 2024 | May 6, 2024 | SEC EDGAR |
| Current report | 8-K | May 1, 2024 | May 1, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 25, 2024 | Apr 26, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2024 | Mar 29, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 18, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2024 | Mar 18, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2024 | Mar 15, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2024 | Mar 8, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 20, 2024 | Feb 23, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 9, 2024 | Jan 12, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 5, 2024 | Jan 8, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 20, 2023 | Nov 24, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 13, 2023 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2023 | Nov 13, 2023 | SEC EDGAR |